title: Promise and pitfalls of molecular markers of thyroid nodules.
abstract: Thyroid nodules are common in the general population with a prevalence of 5-7% The initial evaluation of thyroid nodules commonly involves thyroid function tests, an ultrasound (USG) and fine needle aspiration biopsy (FNAB). The optimal management of patients with thyroid nodules with indeterminate cytology is plagued by the lack of highly sensitive and specific diagnostic modalities In this article we attempt to review the available literature on the molecular markers which are increasingly being studied for their diagnostic utility in assessing thyroid nodules. The various molecular markers consist of gene mutations, gene re arrangements, RNA based assays and immunohistochemical markers. The molecular markers definitely would help to optimise the management of such patients.
authors.affiliation: Department of Endocrinology, Seth GS Medical College and KEM Hospital, Mumbai, Maharashtra, India.
authors.forename: S
authors.initials: S
authors.lastname: Jadhav
authors.forename: Anurag
authors.initials: A
authors.lastname: Lila
authors.forename: Tushar
authors.initials: T
authors.lastname: Bandgar
authors.forename: Nalini
authors.initials: N
authors.lastname: Shah
keywords: Molecular markers; gene rearrangements; genetic mutations; thyroid nodules
references.citation: N Engl J Med. 2012 Aug 23;367(8):705-15
references.pmid: 22731672
references.citation: Adv Anat Pathol. 2001 Nov;8(6):345-54
references.pmid: 11707626
references.citation: Endocr Relat Cancer. 2010 Jan 29;17(1):F91-104
references.pmid: 19942715
references.citation: Thyroid. 2009 Dec;19(12):1351-61
references.pmid: 19895341
references.citation: J Clin Endocrinol Metab. 2001 May;86(5):2187-90
references.pmid: 11344225
references.citation: J Clin Endocrinol Metab. 2011 Nov;96(11):E1719-26
references.pmid: 21865367
references.citation: J Clin Endocrinol Metab. 2008 May;93(5):1600-8
references.pmid: 18270258
references.citation: J Clin Endocrinol Metab. 2003 Jun;88(6):2745-52
references.pmid: 12788883
references.citation: Thyroid. 2009 Dec;19(12):1317-31
references.pmid: 20001715
references.citation: Endocr Pract. 2012 Sep-Oct;18(5):796-802
references.pmid: 22982803
references.citation: J Clin Endocrinol Metab. 2010 Mar;95(3):1365-9
references.pmid: 20130073
references.citation: J Clin Endocrinol Metab. 2011 Nov;96(11):3390-7
references.pmid: 21880806
references.citation: J Clin Endocrinol Metab. 2007 Feb;92(2):468-75
references.pmid: 17118994
references.citation: Endocr Pract. 2010 May-Jun;16(3):468-75
references.pmid: 20551008
references.citation: Am J Pathol. 2003 Apr;162(4):1053-60
references.pmid: 12651598
references.citation: Cancer Cytopathol. 2012 Feb 25;120(1):7-17
references.pmid: 21882358
references.citation: Cytopathology. 2011 Jun;22(3):164-73
references.pmid: 20626438
references.citation: J Clin Oncol. 2003 Sep 1;21(17):3226-35
references.pmid: 12947056
references.citation: J Surg Oncol. 2012 Apr 1;105(5):438-43
references.pmid: 22441894
references.citation: Oncogene. 1991 Sep;6(9):1667-72
references.pmid: 1717926
references.citation: J Clin Endocrinol Metab. 2009 Jun;94(6):2092-8
references.pmid: 19318445
references.citation: Thyroid. 2010 Jul;20(7):697-706
references.pmid: 20578891
references.citation: Oncogene. 1998 Sep 17;17(11 Reviews):1395-413
references.pmid: 9779987
references.citation: J Clin Endocrinol Metab. 2007 Nov;92(11):4085-90
references.pmid: 17785355
references.citation: Am J Surg Pathol. 2002 Aug;26(8):1016-23
references.pmid: 12170088
references.citation: J Clin Endocrinol Metab. 2011 Jul;96(7):2016-26
references.pmid: 21593119